Impact of multi-vessel versus single-vessel disease on outcomes after percutaneous coronary interventions for chronic

Aurel Toma1, Barbara E Stähli2, Michael Gick3

  • 1Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen Suedring 15, 79189, Bad Krozingen, Germany. toma.aurel@gmail.com.

Insights

Successful chronic total occlusion (CTO) revascularization improves survival. Patients with multi-vessel disease (MVD) experience a greater absolute survival benefit from CTO PCI compared to single-vessel disease (SVD) patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Successful revascularization of chronic total occlusions (CTOs) is linked to improved patient prognosis.
  • The impact of coronary artery disease extent on these prognostic benefits remains under-investigated.

Purpose of the Study:

  • To compare survival outcomes after percutaneous coronary intervention (PCI) for CTO in patients with multi-vessel disease (MVD) versus single-vessel disease (SVD).

Main Methods:

  • A cohort of 2002 patients undergoing CTO PCI from 2005-2013 was analyzed.
  • Patients were stratified into MVD and SVD groups.
  • The primary endpoint was all-cause mortality, with a median follow-up of 2.6 years.

Main Results:

  • Multi-vessel disease (MVD) was present in 81.6% of patients.
  • Procedural success rates were 81.5% for MVD and 89.7% for SVD.
  • All-cause mortality was higher in MVD patients (13.5%) vs. SVD patients (5.7%), but the survival benefit of successful CTO PCI was consistent across both groups, with a larger absolute benefit observed in MVD patients due to higher baseline risk.

Conclusions:

  • Successful CTO recanalization is an independent predictor of reduced long-term mortality.
  • While the relative survival benefit is similar, the absolute survival benefit following successful CTO PCI is substantially greater in patients with MVD compared to those with SVD.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
465